Selegiline Hydrochloride Tablet
Product Images NDC 60505-3438

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Selegiline Hydrochloride (NDC 60505-3438). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5mg-60btl (5mg 60btl)

This is a description of Selegiline HCI tablets. Each tablet contains 5 mg of selegiline hydrochloride and should be stored between 20-25°C. The medication is dispensed in a tight, light-resistant container with a child-resistant closure. The inactive ingredients in the medication are citric acid, anhydrous lactose, magnesium stearate, and microcrystalline cellulose. The recommended dosage should be found in the package insert. The manufacturer of Selegiline HCI tablets is Apotex Corp. The rest of the text is not-available or irrelevant.*

FDA Label Image

Structure (Structure)

FDA Label Image

Tablet-symbol (Tablet Symbol)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.